Skip to main content

ORIGINAL RESEARCH article

Front. Oncol., 28 October 2020
Sec. Pediatric Oncology
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.538779

RETRACTED: Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study

Retracted

A retraction of this article was approved in:

  1. Retraction: Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study

    1. Read retraction
Yun-yu Zhang&#x;Yun-yu Zhang1†Qiu-shi Yang&#x;Qiu-shi Yang1†Xia QingXia Qing2Bi-ru LiBi-ru Li1Juan QianJuan Qian1Ying Wang*Ying Wang1*Bo-tao Ning*Bo-tao Ning1*
  • 1Department of Pediatric Intensive Care Unit, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
  • 2Department of Pediatric Hematology and Oncology, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Zhang Y-y, Yang Q-s, Qing X, Li B-r, Qian J, Wang Y and Ning B-t (2020) Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study. Front. Oncol. 10:538779. doi: 10.3389/fonc.2020.538779

Received: 03 March 2020; Accepted: 31 August 2020;
Published: 28 October 2020; Retracted: 03 June 2021.

Edited by:

Christian Flotho, University Freiburg Medical Centre, Children's Hospital, Germany

Reviewed by:

Rachel E. Rau, Baylor College of Medicine, United States
Christina Mayerhofer, University of Freiburg Medical Center, Germany

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.